ZyVersa Therapeutics Inc. (ZVSA)
1.50
0.17 (12.78%)
At close: Jan 14, 2025, 3:59 PM
1.48
-1.33%
Pre-market Jan 15, 2025, 07:36 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | n/a | n/a | n/a | n/a |
| Cost of Revenue | 10.40K | 10.40K | 10.40K | 10.40K |
| Gross Profit | -10.40K | -10.40K | -10.40K | -10.40K |
| Operating Income | -14.42M | -13.01M | -7.70M | -11.83M |
| Interest Income | n/a | 427.54 | 821.37 | 516.45 |
| Pretax Income | -107.75M | -14.05M | -8.08M | -12.68M |
| Net Income | -98.30M | -759.10M | -8.91M | -13.20M |
| Selling & General & Admin | 11.20M | 7.61M | 5.58M | 5.36M |
| Research & Development | 3.21M | 5.41M | 2.12M | 6.47M |
| Other Expenses | n/a | n/a | n/a | n/a |
| Operating Expenses | 14.41M | 13.01M | 7.70M | 11.83M |
| Interest Expense | -457.00K | 427.54K | 821.37K | 516.45K |
| Selling & Marketing Expenses | -11.20B | n/a | n/a | n/a |
| Cost & Expenses | 14.42M | 13.01M | 7.70M | 11.83M |
| Income Tax | -9.46M | 745.05M | 821.37K | 516.45K |
| Shares Outstanding (Basic) | 97.50K | 25.95K | 46.55K | 46.55K |
| Shares Outstanding (Diluted) | 97.50K | 25.95K | 46.55K | 46.55K |
| EPS (Basic) | -1.09K | -930.25 | -173.66 | -272.45 |
| EPS (Diluted) | -1.09K | -930.25 | -173.66 | -272.45 |
| EBITDA | -107.74M | -11.67M | -7.25M | -12.16M |
| Depreciation & Amortization | 10.40K | 10.40K | 10.40K | 10.40K |